ClinicalTrials.Veeva

Menu

Hangover and Residual Zopiclone Effect on Spatial Perception (SEKO-A)

P

Petri Vainio

Status and phase

Unknown
Phase 1

Conditions

Healthy
Alcohol Drinking

Treatments

Drug: Placebo oral capsule
Behavioral: hangover
Drug: Zopiclone

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

Hangover after recreational alcohol use, residual effect of zopiclone and placebo compared in terms of spatial perception, psychomotor tests and simulated driving ability. Three recording visits plus screening included.

Enrollment

16 estimated patients

Sex

All

Ages

18 to 35 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • weight >45 kg
  • likely to experience and predict alcohol hangover within the next five weeks
  • no childbearing potential of negative pregnancy test at screening
  • a valid driving license

Exclusion criteria

  • breastfeeding
  • infection with HCV, HBV or HIV
  • a medical or psychiatric condition or laboratory abnormality that may increase the risk associated with study participation
  • suspected or current drug or alcohol abuse

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

Trial contacts and locations

1

Loading...

Central trial contact

Petri J Vainio, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems